Jonathon C Arnold Selected Research

SB 705498

1/2021

The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a +/- Mouse Model of Dravet Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathon C Arnold Research Topics

Disease

14	Schizophrenia (Dementia Praecox) 01/2019 - 08/2010
11	Epilepsy (Aura) 06/2022 - 01/2016
10	Seizures (Absence Seizure) 01/2022 - 01/2013
9	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022 - 11/2019
6	Psychotic Disorders (Schizoaffective Disorder) 05/2022 - 12/2012
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
3	Body Weight (Weight, Body) 11/2011 - 12/2010
2	Substance-Related Disorders (Drug Abuse) 05/2022 - 10/2010
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Vomiting 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2020 - 01/2012
2	Pain (Aches) 01/2020 - 01/2020
2	Chronic Pain 01/2020 - 01/2019
1	Brain Diseases (Brain Disorder) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Anxiety Disorders (Anxiety Disorder) 09/2021
1	Drug Resistant Epilepsy 01/2021
1	Myocardial Infarction 01/2021
1	Sudden Death 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Lennox Gastaut Syndrome 11/2019
1	Cognitive Dysfunction 01/2019
1	Tourette Syndrome (Tourette's Syndrome) 01/2019
1	Anorexia Nervosa 01/2019
1	Multiple Sclerosis 01/2019
1	Nausea 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 12/2018
1	Back Pain (Backache) 01/2018
1	Marijuana Abuse (Cannabis Abuse) 01/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2012
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Hypothermia 08/2010
1	Neurobehavioral Manifestations 08/2010
1	Catalepsy 08/2010
1	Carcinoma (Carcinomatosis) 09/2008

Drug/Important Bio-Agent (IBA)

12	CannabidiolIBA 06/2022 - 09/2008
11	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 11/2019
9	Pharmaceutical PreparationsIBA 06/2022 - 10/2010
9	CannabinoidsIBA 01/2022 - 04/2008
8	Dronabinol (THC)FDA LinkGeneric 01/2021 - 04/2008
8	Neuregulin-1 (Neuregulin 1)IBA 01/2017 - 06/2011
4	EndocannabinoidsIBA 01/2022 - 06/2005
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
3	Clobazam (HR 376)IBA 12/2021 - 11/2019
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016 - 01/2012
2	Methamphetamine (Desoxyn)FDA LinkGeneric 05/2022 - 12/2012
2	cannabigerolic acidIBA 01/2022 - 12/2021
2	cannabigerolIBA 01/2022 - 01/2021
2	cannabidiolic acidIBA 01/2020 - 11/2019
2	Medical MarijuanaIBA 01/2020 - 01/2018
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2016 - 01/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2013 - 06/2005
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 08/2010 - 06/2005
1	SodiumIBA 06/2022
1	Terpenes (Terpenoids)IBA 06/2022
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022
1	EstersIBA 01/2022
1	olivetolic acidIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Calcium Gluconate (CBG)IBA 01/2022
1	3- (2- nitro- 1- phenylethyl)- 2- phenyl- 1H- indoleIBA 01/2022
1	ABX-1431IBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2021
1	EnzymesIBA 09/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2021
1	Escitalopram FDA Link 09/2021
1	Citalopram FDA LinkGeneric 09/2021
1	Glycine Receptors (Glycine Receptor)IBA 01/2021
1	cannabichromeneIBA 01/2021
1	SB 705498IBA 01/2021
1	OilsIBA 01/2021
1	TRPV1 receptorIBA 01/2021
1	SolutionsIBA 01/2020
1	CytokinesIBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2019
1	AcidsIBA 11/2019
1	ParvalbuminsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 12/2018
1	Clozapine (Clozaril)FDA LinkGeneric 10/2017
1	Antipsychotic Agents (Antipsychotics)IBA 10/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Sigma-1 ReceptorIBA 12/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 02/2013
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2013
1	Illicit Drugs (Recreational Drugs)IBA 01/2012
1	NeuropeptidesIBA 10/2010
1	Oxytocin (Pitocin)FDA LinkGeneric 10/2010
1	CannabinolIBA 09/2008
1	Vincristine (Oncovin)FDA LinkGeneric 09/2008

Therapy/Procedure

7	Induced Hyperthermia (Thermotherapy) 01/2022 - 01/2020
2	Therapeutics 01/2021 - 11/2019
1	Oral Administration 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Aftercare (After-Treatment) 02/2013
1	Withholding Treatment 01/2011
1	Analgesia 08/2010